Iranian Journal of Diabetes and Obesity
Shahid Sadoughi University Of Medical Sciences
Sat, May 18, 2024
[Archive]
Volume 15, Issue 3 (volume 15, number 3 2023)
IJDO 2023, 15(3): 165-174 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Torkashvand Moradabadi M, Hannani S, Torkashvand Z. Epidemilogic Study of Death Caused by Endocrine, Nutritional, and Metabolic Diseases in Iran During 2006-2018. IJDO 2023; 15 (3) :165-174
URL: http://ijdo.ssu.ac.ir/article-1-817-en.html
URL: http://ijdo.ssu.ac.ir/article-1-817-en.html
Assistant Professor of Demography, Faculty of Social Sciences, Yazd University, Yazd, Iran.
Abstract: (590 Views)
Objective: The epidemiological transition and the increase of chronic diseases resulted in the rise of endocrine, nutritional and metabolic (ENM) diseases as causes of death. This study aimed to explore the death rate caused by ENM in Iran 2006-18.
Materials and Methods: Secondary data analysis was done. The demographic data on death were extracted (age, sex and cause of death) at the provincial level from the death records registered by civil registration. The conditions and trends of ENM death were analyzed from 2006 to 2018. The differences were analyzed in terms of age, sex, place of residence, and over time through indicators of death rate, sex ratio, and years of life lost (YLL).
Results: Out of 1708 pregnant women, 244 (14.3%) had GDM, and 1464 (85.7%) did not. There was a statistically significant difference between these two groups in terms of age (P: <0.001), weight (P: <0.001), number of pregnancies (P: <0.001), delivery (P: <0.001), previous diseases (P: <0.001), and Rh (P: 0.01). While in terms of the ABO blood group system (P= 0.3) and abortion rate (P= 0.067), no statistically significant difference was observed.
Conclusion: 6,906 people were died in Iran between 2006- 2018 due to ENM diseases. The death rate from this disease increased from 3.5 per 100,000 people in 2006 to 8.4 in 2018. More women died, especially in old age, with the peak of death being at the age of 50 and older. ENM death resulted in the loss of 67,041 years of life.
Materials and Methods: Secondary data analysis was done. The demographic data on death were extracted (age, sex and cause of death) at the provincial level from the death records registered by civil registration. The conditions and trends of ENM death were analyzed from 2006 to 2018. The differences were analyzed in terms of age, sex, place of residence, and over time through indicators of death rate, sex ratio, and years of life lost (YLL).
Results: Out of 1708 pregnant women, 244 (14.3%) had GDM, and 1464 (85.7%) did not. There was a statistically significant difference between these two groups in terms of age (P: <0.001), weight (P: <0.001), number of pregnancies (P: <0.001), delivery (P: <0.001), previous diseases (P: <0.001), and Rh (P: 0.01). While in terms of the ABO blood group system (P= 0.3) and abortion rate (P= 0.067), no statistically significant difference was observed.
Conclusion: 6,906 people were died in Iran between 2006- 2018 due to ENM diseases. The death rate from this disease increased from 3.5 per 100,000 people in 2006 to 8.4 in 2018. More women died, especially in old age, with the peak of death being at the age of 50 and older. ENM death resulted in the loss of 67,041 years of life.
Type of Study: Research |
Subject:
Special
Received: 2023/05/22 | Accepted: 2023/08/20 | Published: 2023/09/30
Received: 2023/05/22 | Accepted: 2023/08/20 | Published: 2023/09/30
References
1. Shryock HS, Siegel JS, Larmon EA. The methods and materials of demography: US Bureau of the Census; 1975.
2. Ács N, Bánhidy FG, Czeizel AE, editors. Congenital abnormalities and preterm birth related to maternal illnesses during pregnancy. Springer Science & Business Media; 2010:125-47. [DOI:10.1007/978-90-481-8620-4_5]
3. Manoogian EN, Chow LS, Taub PR, Laferrère B, Panda S. Time-restricted eating for the prevention and management of metabolic diseases. Endocrine reviews. 2022;43(2):405-36. [DOI:10.1210/endrev/bnab027]
4. Powell KE, Blair SN. The public health burdens of sedentary living habits: theoretical but realistic estimates. Medicine and science in sports and exercise. 1994;26(7):851-6. [DOI:10.1249/00005768-199407000-00007]
5. World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. World Health Organization; 2013.
6. Karvonen M, Tuomilehto J, Libman I, LaPorte R. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1993;36(10):883-92. [DOI:10.1007/BF02374468]
7. Jahani MA, Eskandari FZ, Mahmoudjanloo S, Mahmoudi G. The Causes of the Mortality of Inpatients in the hospitals covered by Semnan Province Universities of Medical Sciences Based on ICD10. Journal of healthcare management. 2017;8(no3):7-16.(in Persian)
8. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS medicine. 2006;3(11):e442. [DOI:10.1371/journal.pmed.0030442]
9. Khosravi A, Aghamohamadi S, Kazemi E. Mortality profile in the Islamic Republic of Iran 2015 (20 leading cause of death by sex and age group). Tehran: Ministry of Health and Medical Education. 2015.
10. Murray CJ, Lopez AD, World Health Organization. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020: summary. World Health Organization; 1996.
11. Torkashvand Moradabadi M, Torkashvand Z. Epidemiological transition and the importance of social policy: mortality statistic in Ilam, Iran during 2011-2017. Payesh (Health Monitor). 2019;18(4):321-31.(in Persian)
12. Blau DM, Caneer JP, Philipsborn RP, Madhi SA, Bassat Q, Varo R, et al. Overview and development of the child health and mortality prevention surveillance determination of cause of death (DeCoDe) process and DeCoDe diagnosis standards. Clinical Infectious Diseases. 2019;69(Supplement_4):S333-41. [DOI:10.1093/cid/ciz572]
13. Miccoli S. Review of How Population Change Will Transform Our World by Sarah Harper. Springer; 2020. [DOI:10.1186/s41118-020-00075-6]
14. Tessier DM, Lassmann-Vague VJ. Diabetes and education in the elderly. Diabetes & metabolism. 2007;33 Suppl 1:S75-8. [DOI:10.1016/S1262-3636(07)80059-0]
15. Torkashvand Moradabadi M, Abbasi M. An Epidemiological study of mortality among elderly in Iran using Years of Life Lost (YLL) index during 2011 to 2017. Payesh (Health Monitor). 2020;19(1):85-97.(in Persian) [DOI:10.29252/payesh.19.1.85]
16. Aghamohamadi S. Forecasting death trend of endocrine, nutritional, and metabolic diseases in iran during 2006 to 2035. Iranian Journal of Epidemiology. 2018;14(1):63-73.(in Persian)
17. Jafarvand E, Ataey A, Edalati S. Epidemiology and death trends due to diabetes in Iran. Internal Medicine Today. 2021;27(2):198-213. [DOI:10.32598/hms.27.2.2764.1]
18. Bandarian F, Sharifnejad Tehrani Y, Peimani M, Namazi N, Saeedi Moghaddam S, Esmaeili S, Rashidi MM, Nasli Esfahani E, Masinaei M, Rezaei N, Rezaei N. National and sub-national burden and trend of type 1 diabetes in 31 provinces of Iran, 1990-2019. Scientific Reports. 2023;13(1):4210. [DOI:10.1038/s41598-023-31096-8]
19. Wingard DL. The sex differential in morbidity, mortality, and lifestyle. Annual review of public health. 1984;5(1):433-58. [DOI:10.1146/annurev.pu.05.050184.002245]
20. Yun JW, Son M. Forecasting cause-specific mortality in Korea up to year 2032. Journal of Korean medical science. 2016;31(8):1181-9. [DOI:10.3346/jkms.2016.31.8.1181]
21. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes care. 2020;43(Supplement_1):S14-31. [DOI:10.2337/dc20-S002]
22. Prevention CDC. Prevalence of overweight and obesity among adults with diagnosed diabetes--United States, 1988-1994 and 1999-2002. Morbidity and mortality weekly report. 2011;53(19):1066-8.
23. Mendola ND, Chen TC, Gu Q, Eberhardt MS, Saydah S. Prevalence of total, diagnosed, and undiagnosed diabetes among adults: United States, 2013-2016. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2018.
24. Hales CM. Prevalence of Obesity and Severe Obesity Among Adults: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2020.
25. Lin X, Xu Y, Pan X, Xu J, Ding Y, Sun X, et al. Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025. Scientific reports. 2020;10(1):14790. [DOI:10.1038/s41598-020-71908-9]
26. Golden SH, Brown A, Cauley JA, Chin MH, Gary-Webb TL, Kim C, et al. Health disparities in endocrine disorders: biological, clinical, and nonclinical factors-an Endocrine Society scientific statement. The Journal of Clinical Endocrinology & Metabolism. 2012;97(9):E1579-639. [DOI:10.1210/jc.2012-2043]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
